bpc-157 and thymosin beta 4 TB 500 vs BPC 157: Comprehensive comparison of healing peptides BPC-157 + TB-500: Tissue Regeneration

This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic

Click image for larger view

The practical reality involves individual use occurring under this research designation, though such use technically falls outside intended purposes

More serious side effects, like allergic responses or infections, can happen very rarely

This study is the first preclinical pharmacokinetic study of BPC157, and the results are of considerable importance, as they demonstrate not only the pharmacokinetic parameters of BPC157 but also show the implications for its systemic application as a novel drug for various injuries